CYRX

Cryoport Inc

CYRX, USA

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and cryogenic biostorage within the life science industry. Its Life Sciences Products segment offers cryogenic freezers, cryogenic dewars, and accessories within the life science industry through direct sales or a distribution network. The company's products include Cryoport Express Shippers; Cryoport ELITE Shippers; Cryoport Express Cryogenic HV3 Shipping System; Smartpak II Condition Monitoring System and Tec4Med; and Cryoport accessories. It also provides Cryoport BioStorage/Bioservices, such as CRYOGENE, a biostorage solution for the provision of pre-clinical temperature-controlled biological materials management services; and Cryoport Systems Bioservices, including controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release. In addition, the company offers IntegriCell services that comprise apheresis/leukapheresis collection, cryoshuttle transportation, cryo-process optimization, and cryopreservation services; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; CRYOPDP, a temperature-controlled logistics solution; MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; and Vario cryogenic system, a cryogenic freezer system. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. The company was founded in 1999 and is based in Brentwood, Tennessee.

https://www.cryoportinc.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
CYRX
stock
CYRX

A new trading data show CryoPort Inc (CYRX) is showing positive returns. setenews.com

Read more →
CYRX
stock
CYRX

Norges Bank Invests $1.62 Million in CryoPort, Inc. $CYRX MarketBeat

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

Target Price:

$13.2222

Analyst Picks

Strong Buy

4

Buy

2

Hold

4

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very Low

0.95

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-1.35 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-0.90 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-2.86 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

High

0.50

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 103.15% of the total shares of Cryoport Inc

1.

Cadian Capital Management LP

(9.9252%)

since

2025/06/30

2.

Morgan Stanley - Brokerage Accounts

(9.136%)

since

2025/06/30

3.

BlackRock Inc

(8.2278%)

since

2025/06/30

4.

Brown Capital Management, LLC

(7.5878%)

since

2025/06/30

5.

Vanguard Group Inc

(5.5695%)

since

2025/06/30

6.

Fred Alger Management, LLC

(4.7116%)

since

2025/06/30

7.

Millennium Management LLC

(4.4192%)

since

2025/06/30

8.

Thematics Asset Management

(3.8246%)

since

2025/06/30

9.

Alger Small Cap Focus Composite

(3.4081%)

since

2025/06/30

10.

Alger Small Cap Focus I

(3.4081%)

since

2025/06/30

11.

Vanguard Total Stock Mkt Idx Inv

(2.8807%)

since

2025/07/31

12.

Thematics Safety I/A USD

(2.8061%)

since

2024/12/31

13.

Geode Capital Management, LLC

(2.4029%)

since

2025/06/30

14.

iShares Russell 2000 ETF

(2.3511%)

since

2025/08/31

15.

New York State Common Retirement Fund

(2.288%)

since

2025/06/30

16.

Assenagon Asset Management SA

(2.1781%)

since

2025/06/30

17.

Brown Capital Mgmt Small Co Inv

(2.1717%)

since

2025/03/31

18.

Deutsche Bank AG

(1.9758%)

since

2025/06/30

19.

State Street Corp

(1.8804%)

since

2025/06/30

20.

Xtrackers S&P 500 Swap ETF 1C

(1.7141%)

since

2025/07/31

21.

Dimensional Fund Advisors, Inc.

(1.6713%)

since

2025/06/30

22.

Silvercrest Asset Management Group LLC

(1.4753%)

since

2025/06/30

23.

AXA SA

(1.4697%)

since

2025/06/30

24.

AXA Framlington Health Fund - R Income

(1.4697%)

since

2025/07/31

25.

UBS Group AG

(1.2501%)

since

2025/06/30

26.

Edinburgh Worldwide Ord

(1.1651%)

since

2025/06/30

27.

Kennedy Capital Management Inc

(1.0933%)

since

2025/06/30

28.

Vanguard Institutional Extnd Mkt Idx Tr

(1.0822%)

since

2025/07/31

29.

Coeli Circulus Am Micro & Sm Cp I FdrSek

(1.0501%)

since

2025/08/31

30.

Fidelity Small Cap Index

(0.9783%)

since

2025/06/30

31.

Readystate Asset Management LP

(0.969%)

since

2025/06/30

32.

Blackstone Inc

(0.9056%)

since

2025/06/30

33.

Kennedy Micro Cap

(0.898%)

since

2025/06/30

34.

Invesco Technology S&P US Sel Sec ETF

(0.7703%)

since

2025/07/31

35.

Baillie Gifford Global Discovery A Acc

(0.7569%)

since

2025/07/31

36.

Franklin US Small Cap Growth Equity

(0.6995%)

since

2025/06/30

37.

Brown Capital Small Company

(0.6689%)

since

2025/06/30

38.

iShares Russell 2000 Value ETF

(0.659%)

since

2025/08/31

39.

Franklin Small Cap Growth Adv

(0.6476%)

since

2025/07/31

40.

Thematics Meta I/A USD

(0.5994%)

since

2024/12/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

No earnings data available.

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(6)
Defensive
Highly Defensive(6.5)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Some Competitive Advantage(4.8)
GARP
Not Attractive for GARP(2)
Growth
Weak Growth Prospect(1.5)
Momentum
Moderate Momentum(6)
Net Net
Not Undervalued (Net-Net)(2)
Quality
Low Quality Business(2.5)
Value
Fair Value(5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.